Ledger.Open graph →
SEC Form D · Amendment · filed June 13, 2017

Kineta Immuno-Oncology, LLC

Offering
$1.5M
Sold
$238K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Shawn Iadonato · Seattle, WAExec · DirectorGlenn K. Walthall · Belmont, NCExec · DirectorJohn C. Harrison · Nashville, TNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗